Clinical Trial Update: Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating secondary cytoreductive surgery in platinum-resistant recurrent ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Carcinoma

Snippet

Sponsor: Menoufia University | Conditions: Ovarian Cancer, Recurrent Ovarian Carcinoma | Phase 2, Phase 3 | Status: WITHDRAWN